urlscan.io logo urlscan.io
SecurityTrails logo

epivax.com Open in urlscan Pro
34.75.49.244  Public Scan

Back to summary
Submitted URL: http://epivax.com/
Effective URL: https://epivax.com/
Submission: On March 24 via api from US — Scanned from DE

Form analysis 3 forms found in the DOM

GET https://epivax.com/

<form class="is-search-form is-form-style is-form-style-2 is-form-id-10086 " action="https://epivax.com/" method="get" role="search"><label for="is-search-input-10086"><span class="is-screen-reader-text">Search for:</span><input type="search"
      id="is-search-input-10086" name="s" value="" class="is-search-input" placeholder="Search here..." autocomplete="off"></label></form>

GET https://epivax.com/

<form class="is-search-form is-form-style is-form-style-2 is-form-id-10086 " action="https://epivax.com/" method="get" role="search"><label for="is-search-input-10086"><span class="is-screen-reader-text">Search for:</span><input type="search"
      id="is-search-input-10086" name="s" value="" class="is-search-input" placeholder="Search here..." autocomplete="off"></label></form>

GET https://epivax.com/

<form role="search" method="get" class="et-search-form" action="https://epivax.com/">
  <input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:">
</form>

Text Content

 * Our Company
     
   * Company Overview
   * Corporate Responsibility
   * Mission, Vision & Values
   * Team
   * Careers
   * Contact Us
 * Pipeline
     
   * Pipeline Overview
   * BioDefense Vaccines
   * Tregitope: Immunomodulation Power Tool
   * Deimmunization Projects
 * Vaccine Services
     
   * Vaccine Services
   * iVAX: Web-based Vaccine Design
   * PreVAX Analysis
   * EpiCC
 * Immunogenicity Assessment
     
   * Immunogenicity Assessment Overview
   * ISPRI Web-based Immunogenicity Assessment
   * PreDeFT Analysis
   * High Throughput Immunogenicity Analysis
   * PANDA Screening
   * ISPRI for Host Cell Proteins
   * Deimmunization
   * Trusted Expert Advice (TEA) Consulting Services
 * Lab Services
     
   * Lab Services Overview
   * HLA Binding Assays
   * T Cell Assays
 * Press Room
     
   * Press Room
   * Events
     * Webinars
   * Publication & Poster Search
   * Client Testimonials
   * Thinking Out Loud (Blog)
   * Recipes For Success (Podcast)
 * Contact Us
 * Search for:

Select Page
 * Our Company
   * Company Overview
   * Corporate Responsibility
   * Mission, Vision & Values
   * Team
   * Careers
   * Contact Us
 * Pipeline
   * Pipeline Overview
   * BioDefense Vaccines
   * Tregitope: Immunomodulation Power Tool
   * Deimmunization Projects
 * Vaccine Services
   * Vaccine Services
   * iVAX: Web-based Vaccine Design
   * PreVAX Analysis
   * EpiCC
 * Immunogenicity Assessment
   * Immunogenicity Assessment Overview
   * ISPRI Web-based Immunogenicity Assessment
   * PreDeFT Analysis
   * High Throughput Immunogenicity Analysis
   * PANDA Screening
   * ISPRI for Host Cell Proteins
   * Deimmunization
   * Trusted Expert Advice (TEA) Consulting Services
 * Lab Services
   * Lab Services Overview
   * HLA Binding Assays
   * T Cell Assays
 * Press Room
   * Press Room
   * Events
     * Webinars
   * Publication & Poster Search
   * Client Testimonials
   * Thinking Out Loud (Blog)
   * Recipes For Success (Podcast)
 * Contact Us
 * Search for:


 * 
 * 
 * 
 * 


EPIVAX, INC. SUBSIDIARY, EPIVAX THERAPEUTICS SIGNS EXCLUSIVE COLLABORATION
AGREEMENT WITH GREENLIGHT BIOSCIENCES TO DEVELOP PERSONALIZED CANCER VACCINES

Read More


EPIVAX SECURES ADDITIONAL FUNDING FROM FDA FOR IMMUNOGENICITY RISK ASSESSMENT
FOR BIOSIMILAR PRODUCTS

Read More


PUBLICATION: H1N1 G4 SWINE INFLUENZA T CELL EPITOPE ANALYSIS IN SWINE AND HUMAN
VACCINES AND CIRCULATING STRAINS UNCOVERS POTENTIAL RISK TO SWINE AND HUMANS

Read More


PUBLICATION: IN SILICO IMMUNOGENICITY ASSESSMENT FOR SEQUENCES CONTAINING
UNNATURAL AMINO ACIDS: A METHOD USING EXISTING IN SILICO ALGORITHM
INFRASTRUCTURE AND A VISION FOR FUTURE ENHANCEMENTS

Read More


EPIVAX JOINS INTRAVACC, CEPI ON PROJECT TO DEVELOP UNIVERSAL BETACORONAVIRUS
VACCINE

Read More
12345
We are dedicated to applying our tools (in-silico, in-vitro and in-vivo) to
re-engineering therapeutic proteins and to designing new vaccines.



Discover

We take pride in our ability to put our combined intelligence, experience, and
creativity to work to improve human health. Open minds, creative thought and
natural curiosity lead to paradigm shifts. Contact us today to learn more.

Corporate Office/Laboratory:
EpiVax, Inc.
188 Valley Street, Suite 424, Providence, RI 02909 USA
ph: 401.272.2123 fax: 401.272.7562




JOIN OUR NEWSLETTER

We strive to provide our clients, collaborators and everyday immunology
enthusiasts with valuable content.  Written by our CEO/CSO Dr. Anne Dr Groot,
you can expect up to date vaccine development efforts, upcoming events and so
much more from our offices here in Providence, RI.
Click Here



DISCOVER

 * Vaccine Services
 * Immunogenicity Assessment
 * Deimmunization
 * Lab Services
 * Pipeline

ABOUT

 * Our Company
 * Press Room
 * Events
 * Publication & Poster Search
 * Thinking Out Loud (Blog)
 * Contact Us

CONNECT




© 2023 EpiVax, Inc. – Informatics and Immunology, All rights reserved. Privacy
Policy • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 •
fax: 401.272.7562